Chemotherapy-induced peripheral neuropathy — diagnosis, evolution and treatment
Dariusz Iżycki(Poznan University of Medical Sciences), Ewa Nowak‐Markwitz(Poznan University of Medical Sciences), Natalia Iżycka(Poznan University of Medical Sciences), Tomasz Piorunek(Poznan University of Medical Sciences), Adam Niezgoda(Poznan University of Medical Sciences), Bogusława Karaszewska, Maciej Kaźmierczak(Silesian University of Technology)
Cited by 22
Related Papers
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
|The Lancet|2012|3k
Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2022|453
Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial
|Nature Medicine|2022|241